English » Lab Profile » Evi Lianidou

Evi Lianidou

Evi Lianidou, Ph.D.

 Professor of Analytical Chemistry – Clinical Chemistry

Laboratory of Analytical Chemistry

Analysis of Circulating Tumor Cells (ACTC) Lab

Department of Chemistry, University of Athens, Greece

email: lianidou@chem.uoa.gr, evilianidou@gmail.com

 

  Short Summary


Dr. Evi Lianidou is Professor of Analytical Chemistry and Clinical Chemistry at the Department of Chemistry, University of Athens, Greece. Dr Lianidou has established a Molecular Diagnostics Laboratory focused on Liquid Biopsy at the Department of Chemistry since 1998 (http://en.actc-lab.chem.uoa.gr/). Her lab is specializing in the Analysis of Circulating Tumor Cells (ACTC), and has access to many patient samples through extensive clinical collaborations. Her main research interests are on the development and clinical evaluation of: a) single-plex and multiplex quantitative RT-qPCR assays for the detection and molecular characterization of CTCs, b) multiplex assays for gene expression in CTCs based on the liquid bead array, c) DNA methylation assays in CTCs and ctDNA, d) highly sensitive assays for mutation analysis in CTCs and in ctDNA, and evaluation of circulating miRNAs as tumor biomarkers in plasma. Dr. Lianidou has 105 publications (https://www.ncbi.nlm.nih.gov/pubmed/?term=lianidou) and has organized together with Prof K. Pantel: a) the 7th International Symposium on Minimal Residual Disease in Athens, (http://ismrc2009.chem.uoa.gr), b) a scientific meeting on CTCs “Advances in Circulating Tumor Cells: From Basic Research to Clinical Practice” (www.actc2012.org), and c) the 2nd ACTC meeting, (October 8th-11th, 2014), in Crete, Greece (www.actc2014.org). Dr. Lianidou is now organizing the 3rd ACTC meeting, (October 4th-7th, 2017), in Rhodes, Greece (www.actc2017.org). Prof Lianidou is PI in the European TRANSCAN group “CTC-SCAN” and in the EU IMI Network Project “CANCER-ID” (www.cancer-id.eu) and serves on the Editorial Boards of many international journals including Clin Chemistry, Clin. Cancer Res, Breast Cancer Res, Cancer Res, Oncotarget, and many others. Dr. Lianidou is an elected member and Chair of the Committee for Clinical Molecular Biology Curriculum of the International Federation of Clinical Chemistry (IFCC), (http://www.ifcc.org/ifcc-education-division/emd-committees/c-cmbc/) and is coordinating the M.Sc. program of Clinical Chemistry, at the Department of Chemistry, University of Athens (http://en.clinical-chemistry.chem.uoa.gr/).